Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects

ClinicalTrials.gov ID: NCT00432510

Public ClinicalTrials.gov record NCT00432510. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 3:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Protocol LEVP2006-5: Pharmacokinetics of C1INH-nf in Hereditary Angioedema Subjects

Study identification

NCT ID
NCT00432510
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Shire
Industry
Enrollment
27 participants

Conditions and interventions

Interventions

  • C1 esterase inhibitor [human] (C1INH-nf) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 8, 2006
Primary completion
Feb 27, 2007
Completion
Feb 27, 2007
Last update posted
Jun 2, 2021

2006 – 2007

United States locations

U.S. sites
6
U.S. states
5
U.S. cities
6
Facility City State ZIP Site status
University of California, San Diego San Diego California 92093-0732
Allergy and Asthma Clinical Research, Inc. Walnut Creek California 94598
Family Allergy and Asthma Center Atlanta Georgia 30342
Institute for Asthma and Allergy Wheaton Maryland 20902
Penn State University Hershey Pennsylvania 17033
AARA Research Center Dallas Texas 75231

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00432510, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 2, 2021 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00432510 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →